BioSpace News Archive

Press Releases

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

September 29, 2025
·
2 min read
Press Releases

ADvantage Therapeutics Awarded $2.5 milion NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the Clinic

September 29, 2025
·
4 min read
Press Releases

ENHERTU® Demonstrated Highly Statistically Significant and Clinically Meaningful Improvement in Invasive Disease-Free Survival Versus T-DM1 in DESTINY-Breast05 Phase 3 Trial in Patients with High-Risk Early Breast Cancer Following Neoadjuvant Therapy

September 29, 2025
·
20 min read
Press Releases

PureTech Presents New Data from Phase 2b Open-Label Extension Study of Deupirfenidone (LYT-100), Further Supporting Strong and Durable Efficacy and Potential to Serve as New Standard of Care in IPF

September 29, 2025
·
11 min read
Press Releases

Inventiva reports its unaudited 2025 first-half financial results and provides a corporate update

September 29, 2025
·
19 min read
Press Releases

Savara Presents New Data From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society (ERS) Congress 2025

September 29, 2025
·
7 min read
Press Releases

Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model

September 29, 2025
·
15 min read
Press Releases

Virometix Announces Completion of Enrollment in Phase I Trial of V-212 — a Fully Synthetic, Serotype-Independent Vaccine Candidate Against Streptococcus Pneumoniae

September 29, 2025
·
3 min read
Press Releases

Angle PLC Announces Presentation of Data on Glioblastoma

September 29, 2025
·
5 min read
Press Releases

Astellas Announces Top Management Personnel Change

September 29, 2025
·
2 min read